Company intelligence / Profile preview

ScienceIO

New York City, New York, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

ScienceIO is an AI-powered health data platform specializing in transforming unstructured medical and biomedical text into structured, research- and clinic-ready data. It offers advanced NLP and healthcare AI foundation models for applications across patient care, analytics, and administrative workflows. The company was acquired by Veradigm in February 2024 for $140 million.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Mayo Clinic Platform_Accelerate

Beyond the preview

Go deeper on ScienceIO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ScienceIO.

Explore the full profile